Overview

Hemodynamic Protection of Preoperative Ondansetron 15 Minutes Before Spinal Anaesthesia in Caesarean Section

Status:
Completed
Trial end date:
2017-01-02
Target enrollment:
0
Participant gender:
Female
Summary
Spinal anaesthesia for caesarean section is the most commonly used anaesthetic choice in caesarean deliveries. This is usually associated with maternal hypotension and other adverse side effects. Prophylactic intravenous administration of ondansetron immediately and 5 minutes preoperatively have shown to provide a protective effect against hypotension while other studies have shown little effect on the incidence of blood pressure drop in healthy parturients. The investigators will study the effect of different doses and timing of intravenous ondansetron in full term obstetric patients undergoing elective lower segment caesarean section under spinal anaesthesia on the incidence and severity of hypotension and other adverse side effects in healthy parturients having the standard intrathecal plain bupivacaine and fentanyl.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Jordan
Treatments:
Anesthetics
Ondansetron
Criteria
Inclusion Criteria:

- patients who received spinal anesthesia for elective cesarean sections and meet the
American Society of Anesthesiologist's (ASA) patient status classification I or II.

Exclusion Criteria:

- Patients ASA patient status classification III, IV or V

- Emergent cesarean sections

- Multiple parities (twins/triplets)

- More than 1,000 ml blood loss

- More than 6 mg ondansetron administered

- Patients presenting with a cardiac history (coronary artery disease, myocardial
infarction, congestive heart failure, murmur, mitral valve prolapse/regurgitation,
dysrhythmias, aortic stenosis/regurgitation)

- Patients presenting with preeclampsia

- Patients presenting for cesarean section with epidural due to failure to progress.